Biological
Sintilimab plus Chemotherapy
Sintilimab plus Chemotherapy is a biological therapy with 5 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(40%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
1
20%
Ph phase_2
3
60%
Phase Distribution
0
Early Stage
3
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
3(75.0%)
Phase 4Post-market surveillance
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
5
all time
Status Distribution
Active(3)
Completed(1)
Other(1)
Detailed Status
Recruiting2
unknown1
Enrolling by invitation1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 23 (75.0%)
Phase 41 (25.0%)
Trials by Status
unknown120%
enrolling_by_invitation120%
completed120%
recruiting240%
Recent Activity
2 active trials
Showing 5 of 5
recruitingphase_2
Sintilimab Combined With Chemotherapy as Adjuvant Treatment for Phase III GC and GEJ
NCT06761846
enrolling_by_invitationphase_4
Intestinal Microbiota Transplantation, Radiochemotherapy and Sintilimab in Localized Advanced Colon Cancer
NCT06931808
completedphase_2
Sintilimab Plus Chemotherapy Followed by dCRT in Locally Advanced ESCC
NCT03985046
unknown
Detection of Minimal Residual Disease in Resectable Stage II-IIIB Non-small Cell Lung Cancer
NCT06267144
recruitingphase_2
Adriamycin and Ifosfamide Combined With Sintilimab
NCT04589754
Clinical Trials (5)
Showing 5 of 5 trials
NCT06761846Phase 2
Sintilimab Combined With Chemotherapy as Adjuvant Treatment for Phase III GC and GEJ
NCT06931808Phase 4
Intestinal Microbiota Transplantation, Radiochemotherapy and Sintilimab in Localized Advanced Colon Cancer
NCT03985046Phase 2
Sintilimab Plus Chemotherapy Followed by dCRT in Locally Advanced ESCC
NCT06267144
Detection of Minimal Residual Disease in Resectable Stage II-IIIB Non-small Cell Lung Cancer
NCT04589754Phase 2
Adriamycin and Ifosfamide Combined With Sintilimab
All 5 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 5